Seller: California Books, Miami, FL, U.S.A.
Condition: New.
Language: English
Published by World Scientific Pub Co Inc, 2022
ISBN 10: 9811244677 ISBN 13: 9789811244674
Seller: Basi6 International, Irving, TX, U.S.A.
Condition: Brand New. New. US edition. Expediting shipping for all USA and Europe orders excluding PO Box. Excellent Customer Service.
Language: English
Published by World Scientific Pub Co Inc, 2022
ISBN 10: 9811244677 ISBN 13: 9789811244674
Seller: GreatBookPrices, Columbia, MD, U.S.A.
Condition: New.
Language: English
Published by World Scientific Pub Co Inc, 2022
ISBN 10: 9811244677 ISBN 13: 9789811244674
Seller: GreatBookPrices, Columbia, MD, U.S.A.
Condition: As New. Unread book in perfect condition.
Language: English
Published by World Scientific Pub Co Inc, 2022
ISBN 10: 9811244677 ISBN 13: 9789811244674
Seller: GreatBookPricesUK, Woodford Green, United Kingdom
Condition: New.
Language: English
Published by World Scientific Pub Co Inc, 2022
ISBN 10: 9811244677 ISBN 13: 9789811244674
Seller: GreatBookPricesUK, Woodford Green, United Kingdom
Condition: As New. Unread book in perfect condition.
Seller: Majestic Books, Hounslow, United Kingdom
Condition: New.
Hardcover. Condition: Brand New. 250 pages. 9.25x7.50x0.67 inches. In Stock.
Seller: Books Puddle, New York, NY, U.S.A.
Condition: New.
Language: English
Published by World Scientific Pub Co Inc, 2022
ISBN 10: 9811244677 ISBN 13: 9789811244674
Seller: Revaluation Books, Exeter, United Kingdom
Hardcover. Condition: Brand New. 300 pages. 9.00x6.00x0.69 inches. In Stock.
Seller: Biblios, Frankfurt am main, HESSE, Germany
Condition: New.
Language: English
Published by Elsevier Science Publishing Co Inc, 2020
ISBN 10: 0128198400 ISBN 13: 9780128198407
Seller: THE SAINT BOOKSTORE, Southport, United Kingdom
£ 146.95
Quantity: Over 20 available
Add to basketHardback. Condition: New. New copy - Usually dispatched within 4 working days.
Condition: Sehr gut. Zustand: Sehr gut | Sprache: Englisch | Produktart: Bücher | Overcoming Ovarian Cancer Chemoresistance presents non-overlapping review chapters that discuss the state of the field in overcoming chemoresistance of ovarian cancer and treatment options before and following recurrence, considering the genetic makeup of the ovarian cancer patient and her tumor. With the uptake of both germline and somatic gene testing, clinicians can obtain a more comprehensive understanding of ovarian tumors and this book provides information to link the genetic makeup of a tumor (or patient) with the best available treatment. The book discusses topics such as strategies to fight chemo-resistance in ovarian cancer, circulating DNA as a monitor of response, BRCA mutations, ovarian cancer stem cells, immunotherapy and vaccines. Additionally, it brings a list of promising agents at clinical and pre-clinical stage that will impact the treatment in the near future. This book is a valuable source for cancer researchers, oncologists and several members of biomedical field who need to understand how to battle chemoresistance in ovarian cancer.
Seller: Brook Bookstore On Demand, Napoli, NA, Italy
Condition: new. Questo è un articolo print on demand.
Seller: AHA-BUCH GmbH, Einbeck, Germany
Buch. Condition: Neu. nach der Bestellung gedruckt Neuware - Printed after ordering.
Seller: preigu, Osnabrück, Germany
Buch. Condition: Neu. Gynecologic Cancer | Risk Factors, Interception and Prevention | Buch | Englisch | 2026 | MDPI AG | EAN 9783725877935 | Verantwortliche Person für die EU: Libri GmbH, Europaallee 1, 36244 Bad Hersfeld, gpsr[at]libri[dot]de | Anbieter: preigu Print on Demand.
Language: English
Published by Elsevier Science Nov 2020, 2020
ISBN 10: 0128198400 ISBN 13: 9780128198407
Seller: BuchWeltWeit Ludwig Meier e.K., Bergisch Gladbach, Germany
Buch. Condition: Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -Overcoming Ovarian Cancer Chemoresistance presents non-overlapping review chapters that discuss the state of the field in overcoming chemoresistance of ovarian cancer and treatment options before and following recurrence, considering the genetic makeup of the ovarian cancer patient and her tumor. With the uptake of both germline and somatic gene testing, clinicians can obtain a more comprehensive understanding of ovarian tumors and this book provides information to link the genetic makeup of a tumor (or patient) with the best available treatment. The book discusses topics such as strategies to fight chemo-resistance in ovarian cancer, circulating DNA as a monitor of response, BRCA mutations, ovarian cancer stem cells, immunotherapy and vaccines. Additionally, it brings a list of promising agents at clinical and pre-clinical stage that will impact the treatment in the near future. This book is a valuable source for cancer researchers, oncologists and several members of biomedical field who need to understand how to battle chemoresistance in ovarian cancer. 188 pp. Englisch.
Seller: AHA-BUCH GmbH, Einbeck, Germany
Buch. Condition: Neu. nach der Bestellung gedruckt Neuware - Printed after ordering - Overcoming Ovarian Cancer Chemoresistance presents non-overlapping review chapters that discuss the state of the field in overcoming chemoresistance of ovarian cancer and treatment options before and following recurrence, considering the genetic makeup of the ovarian cancer patient and her tumor. With the uptake of both germline and somatic gene testing, clinicians can obtain a more comprehensive understanding of ovarian tumors and this book provides information to link the genetic makeup of a tumor (or patient) with the best available treatment. The book discusses topics such as strategies to fight chemo-resistance in ovarian cancer, circulating DNA as a monitor of response, BRCA mutations, ovarian cancer stem cells, immunotherapy and vaccines. Additionally, it brings a list of promising agents at clinical and pre-clinical stage that will impact the treatment in the near future. This book is a valuable source for cancer researchers, oncologists and several members of biomedical field who need to understand how to battle chemoresistance in ovarian cancer.